Established community pharmacy north of Calgary, co-located with a medical clinic
North of Calgary, AB · Community pharmacy
Year ended March 2026: approximately $3.6M revenue and $919K normalized EBITDA. Pricing guidance available under NDA.
The opportunity
An established community pharmacy in a growing community a short drive north of Calgary on the Highway 2 corridor, sharing its building with an active medical clinic. Revenue has grown for three consecutive years, from approximately $3.0M to $3.6M for the year ended March 2026, with approximately $3.7M in the twelve months to June 2026. Normalized EBITDA for the year ended March 2026 is approximately $919,000, stated after providing the full market cost of a replacement staff pharmacist for every open hour, so the figure does not depend on the owner working the dispensary. The pharmacy dispenses approximately 64,000 prescriptions per year at a 35 percent prescription margin, supported by physician traffic from the clinic in the building and a patient base built over many years. It operates under a national banner, with the banner agreement in place through January 2030. The building is owned by the vendors, a new long term lease will be offered at closing, and a purchase of the building can be discussed. Full financials, lease terms, and the community are released to qualified buyers under NDA.
The numbers, in brief
| Revenue, year ended March 2026 | approximately $3.6M |
|---|---|
| Revenue, trailing twelve months to June 2026 | approximately $3.7M |
| Normalized EBITDA, year ended March 2026 | approximately $919,000 |
| Prescriptions per year | approximately 64,000 |
| Prescription margin | approximately 35 percent |
| Banner agreement | national banner, in place through January 2030 |
Figures are as presented by the vendor and are confirmed from the financial statements under NDA.
Highlights
- ✓Revenue growth three years in a row, from approximately $3.0M to $3.6M, with $3.7M in the trailing twelve months to June 2026
- ✓Normalized EBITDA of approximately $919,000 for the year ended March 2026, stated after a full replacement pharmacist cost
- ✓Approximately 64,000 prescriptions per year at a 35 percent prescription margin
- ✓Shares its building with an active medical clinic
- ✓National banner agreement in place through January 2030
- ✓New long term lease available from the vendor owned building; a purchase of the building can be discussed
Financing at this size
At roughly $919,000 of normalized EBITDA and Alberta multiples of 5.5 to 7.0 times, this is a conventionally bank financed purchase for a qualified buyer rather than a deal that depends on unusual structuring. Canadian lenders typically finance 60 to 75 percent of the purchase price for a pharmacy of this quality and want to see a debt service coverage ratio of at least 1.25 times, which an earnings base of this size supports comfortably. The EBITDA figure is stated after paying a replacement pharmacist for every open hour, so it does not assume the buyer works the dispensary.
For the detail lenders actually ask for, see bank requirements for pharmacy financing in Canada, or run the numbers yourself with the valuation calculator.
Who this suits
- ◆An owner operator pharmacist moving up from a smaller store to an established earnings base
- ◆An existing two or three store group adding a location on the Calgary to Edmonton corridor
- ◆A non pharmacist investor partnering with a licensed pharmacist, since the earnings do not depend on the owner dispensing
Why the details are confidential
Pharmacy sales are sensitive. Staff, patients, suppliers, and competitors must not learn of a sale before the owner chooses. Financials, the exact address, and operational details are shared only with qualified buyers who have signed a non-disclosure agreement.
Looking in this region? See more pharmacies for sale in Alberta, with market multiples and regulatory guidance for the province.
Request the full details
Complete the form and we will start the qualification process, including the NDA. Financials follow immediately after.